Welcome back to Gateway Sessions, the podcast that dives deep into the realms of health, wellness, psychedelics and longevity. I’m your host, Ariane Sommer, and today we are journeying into the microscopic landscape of our biology, specifically zeroing in on the secrets of female reproductive aging. This episode is not just for women, but for...
Get ready for an episode filled with wisdom, compassion and inspiration as we talk with the remarkable Dr. Mark Goulston, who has been admiringly described as a “people hacker”. With his extensive experience as a psychiatrist, executive coach, and consultant to major organizations, Dr. Goulston has made a name for himself as a thought leader...
Real human connection and love is the foundation of individual and collective wellbeing. The lack of true connection is at the root of many issues we are facing as a society. How can we create and deepen authentic connection? Our guest today is Dr. Molly Maloof, the founder and CEO of Adamo Bioscience, a company...
Many still think of MDMA as a substance used by people in their early 20s going to festivals and raves. But new research has revealed MDMA’s promise as a treatment, amongst other, for PTSD and depression. And our guest today sees it as a medicine that can be used to foster connection and enliven and...
There are millions of people around the world who are looking for healing and wellbeing through psychedelics. And the emerging psychedelic wellness industry is looking to help and serve these people. What does it take to manage the daily routine of a psychedelic wellness venture? What are the biggest challenges and how do you establish...
Psilocybin, the active ingredient in magic mushrooms, as well as other psychedelics are being researched as mental health treatments for issues like PTSD, depression, or anxiety. Psilocybin in particular holds great promise to alleviate terminally ill patient’s end-of-life or illness related distress. Our guest today is at the forefront of the fight for the right...
The topic of psychedelic medicines has become part of the global conversation, also because of the mental health challenges we are facing as a result of the COVID-19 pandemic. The paradigm of mental health is shifting. Famous universities are engaged in cutting edge research, hundreds of millions of dollars are raised to invest into psychedelic...
An important part in the emerging field of psychedelic medicines is the use of technology to gather and disseminate data. Today we welcome David Champion on Gateway Sessions. David is the CEO of Maya Health, a company focused on providing psychedelic practitioners with the information and technology they need to scale psychedelic healthcare smartly and...
The modern state of psychedelics is exciting as well as daunting. What does it mean to invest in the business of psychedelics and how is the legal landscape evolving after decades of research into compounds that show promise for trauma-based mental health disorders, addictions and more? How can and must this field be navigated ethically...
We are currently witnessing the unfolding of the Psychedelic Time. Major global neuroscience research institutes are focusing on psychedelic research projects. The field of psychedelics is not fringe anymore. It is part of cutting edge neuroscience and healthcare research. And it is where psychiatry is heading. Our guest today is at the forefront of psychedelic research...